Pour la surveillance intensive après traitement des cancers du sein

Sebban, E

doi:10.1016/j.gyobfe.2006.01.023

Cited by 3 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ASCO (American Society of Clinical Oncology) recommends for this purpose a clinical monitoring based on the interrogation and clinical examination every 4 months for 3 years, then every 6 months for the next 2 years, then once per year for the rest of life [3]. Regarding the paraclinical How to cite this paper: Dia, J.M., Saki, C., Mouhideen, O., Bohoussou, E., Touré, M., Okon, G., Guié check up, only mammography and breast ultrasound should be performed annually, and other tests (chest radiograph, tumor markers, abdominal-pelvic ultrasound, bone scan...) will be proposed only in case of complaint signs [4].…”

Section: Introductionmentioning

confidence: 99%

Epidemiological Aspects of Metastatic Relapse of Breast Cancer in an African Context

Dia¹,

Saki²,

Oyelade³

et al. 2017

OJOG

View full text Add to dashboard Cite

Objectives: This study aimed to describe the epidemiological characteristics of metastatic relapse in breast cancer at the University and Hospital Center of Treichville. Methodology: This is a cohort and retrospective study conducted from January 2000 to December 2015 on 178 patients with metastaticrelapse in breast cancer. Results: The prevalence of metastatic relapses was 49% and the patients had an average age of 53.4 years and among them, 91.6% received school education and 88.2% did not have a high socioeconomic level. The majority of initial tumors were in Stage III (47.8%), SBR III (47.2%), High Ki 67 (46.5%), Negative RH (79.3%), and HER2 negative (58%). Metastases were generally unique (62.9%), dominated by bone sites (36.6%), with an average occurrencedelay of 2.4 years. After the occurrence of metastases, the cumulative survival rate was 5% at 3 years, and nil at 5 years. Conclusion: Metastatic relapses were common with poor prognosis.

show abstract

Section: Introductionmentioning

confidence: 99%

Epidemiological Aspects of Metastatic Relapse of Breast Cancer in an African Context

Dia¹,

Saki²,

Oyelade³

et al. 2017

OJOG

View full text Add to dashboard Cite

show abstract

“…For additional examinations, only mammography and breast ultrasound should be performed annually, and other tests (chest x-ray, tumor markers, abdomino-pelvic ultrasound, bone scintigraphy, etc.) will be proposed only before functional signs [4].…”

Section: Introductionmentioning

confidence: 99%

Occurrence Delays of Metastatic Relapses of Breast Cancers Treated at University Hospital of Treichville (Abidjan-Cote d’Ivoire)

Djanhan¹,

Dia²,

Mian³

et al. 2017

JCT

View full text Add to dashboard Cite

Objective: Describe the occurrence delays of metastatic relapses of breast cancer based on the characteristics of the original tumor. Methodology: This is a retrospective and cohort study conducted from January 2000 to December 2015 on patients with metastatic relapse of breast cancer. Results: Out of 178 patients collected, the metastatic relapses were estimated at 49%, occurring in patients with an average age of 53.4 years. The majority of the patients was educated (91.6%) and did not have a high socioeconomic level (88.2%). The initial tumors were mainly at a clinical stage III (47.8%), SBR grade III (47.2%), high index Ki 67 (46.5%), negative RH (79.3%) and HER2 negative (58%). Metastases were unique in general (62.9%), dominated by bone locations (36.6%), with an average age of occurrence of 2.4 years. After the occurrence of these metastases, the cumulative survival rate was 5% at 3 years, and zero to 5 years. Conclusion: Metastatic relapses were common with poor prognosis.

show abstract

Qualité de vie de patientes en rémission traitées pour un cancer du sein non métastasé, selon la surveillance médicale classique ou alternée

Lantheaume

Conceição²,

Bosset

et al. 2014

Psycho Oncologie

View full text Add to dashboard Cite

Pour la surveillance intensive après traitement des cancers du sein

Cited by 3 publications

References 6 publications

Epidemiological Aspects of Metastatic Relapse of Breast Cancer in an African Context

Epidemiological Aspects of Metastatic Relapse of Breast Cancer in an African Context

Occurrence Delays of Metastatic Relapses of Breast Cancers Treated at University Hospital of Treichville (Abidjan-Cote d’Ivoire)

Qualité de vie de patientes en rémission traitées pour un cancer du sein non métastasé, selon la surveillance médicale classique ou alternée

Contact Info

Product

Resources

About